Innoviva, Inc. (INVA)
USD 17.34
(-2.14%)
USD 17.34
(-2.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 179.72 Million USD | -15.99% |
| 2022 | 213.92 Million USD | -42.0% |
| 2021 | 368.83 Million USD | 64.36% |
| 2020 | 224.4 Million USD | 42.67% |
| 2019 | 157.28 Million USD | -60.19% |
| 2018 | 395.05 Million USD | 194.5% |
| 2017 | 134.14 Million USD | 125.31% |
| 2016 | 59.53 Million USD | 417.36% |
| 2015 | -18.76 Million USD | 88.86% |
| 2014 | -168.46 Million USD | 1.31% |
| 2013 | -170.7 Million USD | -820.62% |
| 2012 | -18.54 Million USD | 83.92% |
| 2011 | -115.34 Million USD | -37.54% |
| 2010 | -83.86 Million USD | 1.69% |
| 2009 | -85.3 Million USD | 8.91% |
| 2008 | -93.64 Million USD | 41.47% |
| 2007 | -159.99 Million USD | 3.64% |
| 2006 | -166.04 Million USD | -15.98% |
| 2005 | -143.16 Million USD | -39.46% |
| 2004 | -102.65 Million USD | -45.44% |
| 2003 | -70.58 Million USD | 10.91% |
| 2002 | -79.22 Million USD | -22.18% |
| 2001 | -64.84 Million USD | 31.7% |
| 2000 | -94.93 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -34.68 Million USD | -194.94% |
| 2024 Q1 | 36.53 Million USD | -40.63% |
| 2023 Q1 | 34.86 Million USD | 151.04% |
| 2023 Q4 | 61.53 Million USD | -25.0% |
| 2023 Q3 | 82.04 Million USD | 6309.84% |
| 2023 Q2 | 1.28 Million USD | -96.33% |
| 2023 FY | 179.72 Million USD | -15.99% |
| 2022 Q1 | 37.85 Million USD | 265.95% |
| 2022 Q4 | -68.31 Million USD | -125.73% |
| 2022 FY | 213.92 Million USD | -42.0% |
| 2022 Q3 | 265.52 Million USD | 1142.45% |
| 2022 Q2 | 21.37 Million USD | -43.55% |
| 2021 FY | 368.83 Million USD | 64.36% |
| 2021 Q1 | 94.12 Million USD | 74.62% |
| 2021 Q3 | 72.43 Million USD | -18.56% |
| 2021 Q4 | 10.34 Million USD | -85.72% |
| 2021 Q2 | 88.94 Million USD | -5.5% |
| 2020 Q1 | 65.43 Million USD | 42.41% |
| 2020 FY | 224.4 Million USD | 42.67% |
| 2020 Q2 | 76.84 Million USD | 17.43% |
| 2020 Q3 | 28.21 Million USD | -63.28% |
| 2020 Q4 | 53.9 Million USD | 91.02% |
| 2019 Q4 | 45.94 Million USD | 15.42% |
| 2019 Q3 | 39.8 Million USD | 5.48% |
| 2019 Q2 | 37.74 Million USD | 11.69% |
| 2019 FY | 157.28 Million USD | -60.19% |
| 2019 Q1 | 33.79 Million USD | -87.19% |
| 2018 FY | 395.05 Million USD | 194.5% |
| 2018 Q4 | 263.76 Million USD | 460.13% |
| 2018 Q1 | 29.58 Million USD | -49.33% |
| 2018 Q2 | 54.62 Million USD | 84.67% |
| 2018 Q3 | 47.08 Million USD | -13.8% |
| 2017 Q2 | 35.14 Million USD | 108.64% |
| 2017 FY | 134.14 Million USD | 125.31% |
| 2017 Q4 | 58.38 Million USD | 145.66% |
| 2017 Q3 | 23.76 Million USD | -32.38% |
| 2017 Q1 | 16.84 Million USD | -33.86% |
| 2016 Q3 | 15.03 Million USD | 2.99% |
| 2016 Q4 | 25.47 Million USD | 69.43% |
| 2016 Q1 | 4.43 Million USD | 3.12% |
| 2016 Q2 | 14.59 Million USD | 229.13% |
| 2016 FY | 59.53 Million USD | 417.36% |
| 2015 Q4 | 4.3 Million USD | 193.83% |
| 2015 Q2 | -7.81 Million USD | 26.78% |
| 2015 Q1 | -10.66 Million USD | 33.02% |
| 2015 Q3 | -4.58 Million USD | 41.31% |
| 2015 FY | -18.76 Million USD | 88.86% |
| 2014 FY | -168.46 Million USD | 1.31% |
| 2014 Q4 | -15.92 Million USD | 25.13% |
| 2014 Q3 | -21.27 Million USD | 66.54% |
| 2014 Q2 | -63.56 Million USD | 6.11% |
| 2014 Q1 | -67.7 Million USD | -35.6% |
| 2013 Q1 | -37.36 Million USD | -19.27% |
| 2013 Q4 | -49.92 Million USD | -6.27% |
| 2013 Q3 | -46.98 Million USD | -28.98% |
| 2013 Q2 | -36.42 Million USD | 2.49% |
| 2013 FY | -170.7 Million USD | -820.62% |
| 2012 FY | -18.54 Million USD | 83.92% |
| 2012 Q1 | 84.59 Million USD | 328.59% |
| 2012 Q3 | -34.69 Million USD | 6.54% |
| 2012 Q4 | -31.32 Million USD | 9.71% |
| 2012 Q2 | -37.12 Million USD | -143.88% |
| 2011 Q2 | -25.04 Million USD | -10.49% |
| 2011 Q3 | -30.62 Million USD | -22.28% |
| 2011 Q4 | -37 Million USD | -20.84% |
| 2011 FY | -115.34 Million USD | -37.54% |
| 2011 Q1 | -22.66 Million USD | -17.45% |
| 2010 Q1 | -22.53 Million USD | -1.47% |
| 2010 Q4 | -19.29 Million USD | 9.06% |
| 2010 Q3 | -21.22 Million USD | -2.0% |
| 2010 FY | -83.86 Million USD | 1.69% |
| 2010 Q2 | -20.8 Million USD | 7.68% |
| 2009 FY | -85.3 Million USD | 8.91% |
| 2009 Q4 | -22.21 Million USD | -0.12% |
| 2009 Q2 | -21.69 Million USD | -12.88% |
| 2009 Q1 | -19.21 Million USD | -20.67% |
| 2009 Q3 | -22.18 Million USD | -2.26% |
| 2008 FY | -93.64 Million USD | 41.47% |
| 2008 Q1 | -29.76 Million USD | 9.96% |
| 2008 Q4 | -15.92 Million USD | 23.91% |
| 2008 Q3 | -20.92 Million USD | 22.56% |
| 2008 Q2 | -27.02 Million USD | 9.2% |
| 2007 Q3 | -32.36 Million USD | 28.28% |
| 2007 FY | -159.99 Million USD | 3.64% |
| 2007 Q2 | -45.12 Million USD | 8.75% |
| 2007 Q4 | -33.05 Million USD | -2.14% |
| 2007 Q1 | -49.45 Million USD | -30.69% |
| 2006 FY | -166.04 Million USD | -15.98% |
| 2006 Q4 | -37.83 Million USD | -0.15% |
| 2006 Q1 | -48.95 Million USD | -15.97% |
| 2006 Q2 | -41.47 Million USD | 15.27% |
| 2006 Q3 | -37.78 Million USD | 8.91% |
| 2005 Q1 | -31.45 Million USD | -7.82% |
| 2005 Q3 | -37.78 Million USD | -19.14% |
| 2005 FY | -143.16 Million USD | -39.46% |
| 2005 Q4 | -42.21 Million USD | -11.71% |
| 2005 Q2 | -31.71 Million USD | -0.84% |
| 2004 Q2 | -25.59 Million USD | 0.0% |
| 2004 Q3 | -22.28 Million USD | 12.93% |
| 2004 Q4 | -29.17 Million USD | -30.89% |
| 2004 FY | -102.65 Million USD | -45.44% |
| 2003 FY | -70.58 Million USD | 10.91% |
| 2002 FY | -79.22 Million USD | -22.18% |
| 2001 FY | -64.84 Million USD | 31.7% |
| 2000 FY | -94.93 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | 222.763% |
| Alkermes plc | 355.75 Million USD | 49.482% |
| Agenus Inc. | -245.76 Million USD | 173.129% |
| Aptorum Group Limited | -2.82 Million USD | 6462.636% |
| Ardelyx, Inc. | -66.06 Million USD | 372.03% |
| Dyadic International, Inc. | -6.79 Million USD | 2744.736% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 19301.068% |
| Lantern Pharma Inc. | -15.96 Million USD | 1225.969% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 1044.47% |
| Novavax, Inc. | -545.06 Million USD | 132.973% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 408.308% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 343.559% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 1069.056% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 1899.74% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 404.703% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 148.102% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 838.403% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 581.312% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 209.204% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 345.03% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 985.723% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 388.687% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 653.246% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 235.646% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 140.823% |
| AlloVir, Inc. | -190.41 Million USD | 194.383% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 187.552% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 731.667% |
| Bicycle Therapeutics plc | -180.66 Million USD | 199.479% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 200.374% |
| ChromaDex Corporation | -4.93 Million USD | 3739.571% |
| Chimerix, Inc. | -82.09 Million USD | 318.92% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 502.934% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 276.077% |
| CRISPR Therapeutics AG | -153.61 Million USD | 216.999% |
| Precision BioSciences, Inc. | -61.31 Million USD | 393.093% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 211.679% |
| Fortress Biotech, Inc. | -60.63 Million USD | 396.39% |
| Fortress Biotech, Inc. | -60.63 Million USD | 396.39% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 320.302% |
| ImmuCell Corporation | -5.77 Million USD | 3212.286% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 259.101% |
| Immix Biopharma, Inc. | -15.42 Million USD | 1265.055% |
| Incyte Corporation | 597.59 Million USD | 69.926% |
| IO Biotech, Inc. | -86.08 Million USD | 308.778% |
| Jaguar Health, Inc. | -41.3 Million USD | 535.162% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 217.472% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -244.599% |
| ContextLogic Inc. | -317 Million USD | 156.695% |
| MiMedx Group, Inc. | 67.43 Million USD | -166.496% |
| MEI Pharma, Inc. | 17.77 Million USD | -910.924% |
| NextCure, Inc. | -62.72 Million USD | 386.533% |
| Onconetix, Inc. | -37.4 Million USD | 580.416% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 555.234% |
| Opthea Limited | -220.24 Million USD | 181.602% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 451.301% |
| Vaxcyte, Inc. | -402.26 Million USD | 144.677% |
| PDS Biotechnology Corporation | -42.94 Million USD | 518.521% |
| Precigen, Inc. | -95.9 Million USD | 287.398% |
| Pharming Group N.V. | -10.54 Million USD | 1803.849% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 189.151% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 832.274% |
| PureTech Health plc | -65.69 Million USD | 373.562% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 816.281% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 184.687% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 838.403% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 169.705% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 759.821% |
| Acelyrin, Inc. | -381.64 Million USD | 147.092% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 1432982.42% |
| Summit Therapeutics Inc. | -614.92 Million USD | 129.227% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 627.029% |
| Senti Biosciences, Inc. | -92.91 Million USD | 293.418% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 271.656% |
| Elevation Oncology, Inc. | -45.7 Million USD | 493.23% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 611.446% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 1474.877% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 2788.437% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 712.09% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 2214.128% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 412.489% |
| Seer, Inc. | -86.27 Million USD | 308.308% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 368.262% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 373.279% |
| ESSA Pharma Inc. | -26.58 Million USD | 776.095% |
| GlycoMimetics, Inc. | -36.89 Million USD | 587.059% |
| GT Biopharma, Inc. | -7.59 Million USD | 2465.697% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 174.462% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | 446.118% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -151.676% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 430.238% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 465.884% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 1906.661% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 131.374% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | 5108.974% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 451.996% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 173.178% |
| Aptose Biosciences Inc. | -51.2 Million USD | 450.972% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 282.834% |
| Soligenix, Inc. | -6.14 Million USD | 3026.72% |
| Century Therapeutics, Inc. | -136.67 Million USD | 231.498% |
| Kura Oncology, Inc. | -152.63 Million USD | 217.749% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 301.441% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 1805.466% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -31682.765% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 31685.589% |
| Autolus Therapeutics plc | -208.38 Million USD | 186.246% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 349.968% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 353.863% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 929.435% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 179.788% |
| GRI Bio, Inc. | -13.03 Million USD | 1478.553% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 4446.804% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 244.839% |
| IGM Biosciences, Inc. | -246.41 Million USD | 172.934% |
| INmune Bio, Inc. | -30 Million USD | 698.914% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 262.558% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 525.944% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 1225.961% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 1237.842% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 401.118% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 277.649% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 165.087% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 175.548% |
| Verastem, Inc. | -87.36 Million USD | 305.709% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 431.664% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 211.396% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 254.059% |
| Histogen Inc. | -10.62 Million USD | 1792.138% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 1357.962% |
| Surrozen, Inc. | -43.04 Million USD | 517.55% |
| Organovo Holdings, Inc. | -14.67 Million USD | 1325.015% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 3632.946% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 443.381% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 811.404% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 767.169% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 2250.534% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 218.954% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 467.334% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 704.616% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 1825.159% |
| Apollomics, Inc. | -172.6 Million USD | 204.126% |
| Amarin Corporation plc | -59.11 Million USD | 404.036% |
| Mesoblast Limited | -87.95 Million USD | 304.332% |
| Turnstone Biologics Corp. | -55.2 Million USD | 425.583% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 222.291% |
| Synaptogenix, Inc. | -6.03 Million USD | 3076.267% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 1208.847% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 330.354% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 3850.877% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 2238.988% |
| Exelixis, Inc. | 207.76 Million USD | 13.497% |
| Better Therapeutics, Inc. | -39.76 Million USD | 552.017% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 224.852% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 133.998% |
| NLS Pharmaceutics AG | -12.17 Million USD | 1576.516% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 2405.698% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 684.481% |
| Gritstone bio, Inc. | -138.49 Million USD | 229.773% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 378.79% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 4593.106% |
| Avid Bioservices, Inc. | -140.75 Million USD | 227.686% |
| Insmed Incorporated | -749.56 Million USD | 123.977% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 1283.198% |
| MediWound Ltd. | -6.71 Million USD | 2776.027% |
| OmniAb, Inc. | -50.61 Million USD | 455.048% |
| Alector, Inc. | -130.39 Million USD | 237.833% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 258.033% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 446.639% |
| Zai Lab Limited | -334.62 Million USD | 153.709% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 155.472% |
| Aura Biosciences, Inc. | -76.4 Million USD | 335.214% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 176.597% |
| Immunic, Inc. | -93.61 Million USD | 291.986% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 232.253% |
| Veracyte, Inc. | -74.4 Million USD | 341.549% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 2441.487% |
| FibroGen, Inc. | -284.23 Million USD | 163.231% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 785.125% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 2666.764% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 1054.309% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 56.676% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 896.817% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -264.762% |
| TG Therapeutics, Inc. | 12.67 Million USD | -1318.261% |
| Galecto, Inc. | -38.34 Million USD | 568.648% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 1052.624% |
| Fortrea Holdings Inc. | -3.4 Million USD | 5385.941% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 241.911% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 1132.232% |
| XBiotech Inc. | -24.55 Million USD | 831.856% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 378.79% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 386.729% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 282.596% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 938.764% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 425.625% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 129.626% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 363.31% |
| Vaxxinity, Inc. | -56.93 Thousand USD | 315767.264% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 179.334% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 907.104% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 181.8% |
| NexImmune, Inc. | -32.34 Million USD | 655.651% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 3499.593% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 1379.534% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 95.454% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 842.009% |
| Scopus BioPharma Inc. | -11.6 Million USD | 1648.016% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 253.874% |
| Ainos, Inc. | -13.77 Million USD | 1405.119% |
| Pluri Inc. | -20.88 Million USD | 960.408% |
| Prothena Corporation plc | -147.02 Million USD | 222.237% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 257.829% |
| Celularity Inc. | -196.29 Million USD | 191.557% |
| Rallybio Corporation | -74.56 Million USD | 341.031% |
| Cue Biopharma, Inc. | -50.73 Million USD | 454.251% |
| MeiraGTx Holdings plc | -84.02 Million USD | 313.886% |
| Omeros Corporation | -117.81 Million USD | 252.549% |
| Humacyte, Inc. | -110.77 Million USD | 262.239% |
| Immunocore Holdings plc | -55.28 Million USD | 425.071% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 1099.344% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 883.751% |
| Blueprint Medicines Corporation | -506.98 Million USD | 135.449% |
| CalciMedica, Inc. | -34.35 Million USD | 623.102% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 365.566% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 227.097% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 208.404% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 163.449% |
| Pulmatrix, Inc. | -14.12 Million USD | 1372.729% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 610.646% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 317.481% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 137.349% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 271.374% |
| Cytokinetics, Incorporated | -526.24 Million USD | 134.152% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 598.328% |
| Nutriband Inc. | -5.48 Million USD | 3376.421% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 544.636% |
| Vor Biopharma Inc. | -117.86 Million USD | 252.484% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 95.867% |
| Evogene Ltd. | -23.87 Million USD | 852.636% |
| ProKidney Corp. | -35.46 Million USD | 606.716% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 250.065% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 2390.798% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 127.942% |
| CorMedix Inc. | -46.33 Million USD | 487.84% |
| BioLineRx Ltd. | -60.61 Million USD | 396.502% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 276.641% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 537.642% |
| Atai Life Sciences N.V. | -40.22 Million USD | 546.803% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 322.841% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 337.976% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 161.508% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 744.719% |
| MediciNova, Inc. | -8.57 Million USD | 2196.735% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 245.787% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 2245.465% |
| GeoVax Labs, Inc. | -25.96 Million USD | 792.123% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 175.123% |
| Biomea Fusion, Inc. | -117.25 Million USD | 253.274% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 128.682% |
| Mereo BioPharma Group plc | -29.46 Million USD | 709.93% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 217.341% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 185.844% |
| Absci Corporation | -110.56 Million USD | 262.547% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 696.093% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 278.23% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 176.174% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -1176.072% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 193.139% |
| Allakos Inc. | -185.7 Million USD | 196.78% |
| Imunon, Inc. | -19.51 Million USD | 1020.944% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 284.643% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -69.325% |
| BioAtla, Inc. | -123.46 Million USD | 245.569% |
| NLS Pharmaceutics AG | -12.17 Million USD | 1576.516% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | 1217.813% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 154.916% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 586.406% |
| XOMA Corporation | -40.83 Million USD | 540.161% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 276.423% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 251.647% |
| aTyr Pharma, Inc. | -50.38 Million USD | 456.669% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 304.977% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 218.426% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 175.598% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 611.751% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 2321.0% |
| Akari Therapeutics, Plc | -10 Million USD | 1895.783% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 267046.899% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 36.177% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 2796.545% |
| UroGen Pharma Ltd. | -102.24 Million USD | 275.778% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 268.29% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | 2410.888% |
| Orgenesis Inc. | -55.36 Million USD | 424.636% |
| Entera Bio Ltd. | -8.88 Million USD | 2121.847% |
| GH Research PLC | -35.58 Million USD | 605.021% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 962.39% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 332.235% |
| Xencor, Inc. | -126.08 Million USD | 242.538% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 4872.603% |
| Replimune Group, Inc. | -215.79 Million USD | 183.284% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 945.093% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -7063.093% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 2796.545% |
| Portage Biotech Inc. | -75.33 Million USD | 338.551% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 2245.465% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 285.942% |
| OncoCyte Corporation | -27.78 Million USD | 746.924% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 1439.488% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 1715.984% |
| Purple Biotech Ltd. | -19.88 Million USD | 1004.034% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 2660.507% |
| scPharmaceuticals Inc. | -54.81 Million USD | 427.9% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 1126.623% |
| HilleVax, Inc. | -123.56 Million USD | 245.446% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 1878.193% |
| Tharimmune, Inc. | -9.31 Million USD | 2028.535% |
| Genprex, Inc. | -30.86 Million USD | 682.37% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 176.178% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 697.202% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 10185.41% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 3493.533% |
| OKYO Pharma Limited | -16.82 Thousand USD | 1068255.046% |
| Savara Inc. | -54.69 Million USD | 428.571% |
| Curis, Inc. | -47.41 Million USD | 479.056% |
| Daré Bioscience, Inc. | -30.16 Million USD | 695.868% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 1263.619% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 3327.186% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 702.791% |
| BeiGene, Ltd. | -881.7 Million USD | 120.383% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 944.003% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 141.186% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 327.626% |
| Erasca, Inc. | -125.04 Million USD | 243.729% |
| bluebird bio, Inc. | -211.91 Million USD | 184.809% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 3694.083% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -7.204% |
| DBV Technologies S.A. | -72.72 Million USD | 347.122% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 3694.083% |
| Moderna, Inc. | -4.71 Billion USD | 103.813% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 547.548% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 3256.34% |
| Molecular Templates, Inc. | -8.12 Million USD | 2312.235% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 397.612% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 261.332% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 232.781% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 475.054% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 227.076% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 193.406% |
| MacroGenics, Inc. | -9.05 Million USD | 2084.125% |
| RenovoRx, Inc. | -10.23 Million USD | 1856.47% |
| Adicet Bio, Inc. | -142.65 Million USD | 225.981% |
| Prime Medicine, Inc. | -198.13 Million USD | 190.708% |
| Aditxt, Inc. | -32.38 Million USD | 655.026% |
| Adagene Inc. | -18.94 Million USD | 1048.583% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 2557.998% |
| Quantum-Si incorporated | -95.96 Million USD | 287.288% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 250.99% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 1332.85% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -35.813% |
| SciSparc Ltd. | -5.12 Million USD | 3608.825% |
| Vericel Corporation | -3.18 Million USD | 5748.083% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 149551.993% |
| Minerva Neurosciences, Inc. | -30 Million USD | 698.966% |
| Generation Bio Co. | -126.61 Million USD | 241.947% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 346.563% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 317.998% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 168.56% |
| Invivyd, Inc. | -198.64 Million USD | 190.475% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 152.554% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 2168.963% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -688.047% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 1920.154% |
| 2seventy bio, Inc. | -217.57 Million USD | 182.604% |
| ADMA Biologics, Inc. | -28.23 Million USD | 736.432% |
| Clene Inc. | -49.5 Million USD | 463.045% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 906.379% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 463.559% |
| GeoVax Labs, Inc. | -25.96 Million USD | 792.123% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 154.782% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 652.262% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -691.03% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 281.92% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 340.418% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 211.764% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 129.22% |
| Evaxion Biotech A/S | -22.12 Million USD | 912.303% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 322.605% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 189.83% |
| Trevena, Inc. | -40.28 Million USD | 546.082% |
| Surrozen, Inc. | -43.04 Million USD | 517.55% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 359.962% |
| Cingulate Inc. | -23.53 Million USD | 863.639% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 2700.145% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 550.883% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 2430.821% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 299.226% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 393.251% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 402.039% |
| Clearmind Medicine Inc. | -11.95 Million USD | 1603.317% |
| Kronos Bio, Inc. | -112.67 Million USD | 259.508% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 359.725% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 7086286.978% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 309.235% |
| Statera Biopharma, Inc. | -174.4 Million USD | 203.047% |
| ImmunityBio, Inc. | -583.19 Million USD | 130.817% |
| Korro Bio, Inc. | -81.17 Million USD | 321.409% |
| Kineta, Inc. | -14.09 Million USD | 1374.715% |
| BioVie Inc. | -32.12 Million USD | 659.524% |
| Codexis, Inc. | -76.24 Million USD | 335.732% |
| Celularity Inc. | -196.29 Million USD | 191.557% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 183.775% |
| Celcuity Inc. | -63.77 Million USD | 381.788% |
| Virax Biolabs Group Limited | -6.73 Million USD | 2769.058% |
| Cibus, Inc. | -267.62 Million USD | 167.154% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 545.673% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 601.863% |
| IN8bio, Inc. | -30 Million USD | 698.934% |
| Kodiak Sciences Inc. | -260.49 Million USD | 168.994% |
| Annexon, Inc. | -134.23 Million USD | 233.884% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 253.392% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 393.529% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 669.75% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 149.066% |
| Eyenovia, Inc. | -27.26 Million USD | 759.262% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -732.393% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 33692.897% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 335.226% |
| Arcellx, Inc. | -70.69 Million USD | 354.24% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 533.682% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 234.305% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 698.335% |
| Moolec Science SA | -51.78 Million USD | 447.028% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 443.171% |
| Geron Corporation | -184.12 Million USD | 197.608% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 528.175% |
| Royalty Pharma plc | 1.13 Billion USD | 84.163% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 232.191% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 2121.21% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 946.02% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 204.69% |
| Humacyte, Inc. | -110.77 Million USD | 262.239% |
| Structure Therapeutics Inc. | -89.62 Million USD | 300.538% |
| 89bio, Inc. | -142.18 Million USD | 226.397% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 360.618% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 1831.926% |
| Genelux Corporation | -28.29 Million USD | 735.127% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 718.345% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 201.47% |
| Notable Labs, Ltd. | -11.26 Million USD | 1695.543% |
| Liquidia Corporation | -78.5 Million USD | 328.939% |
| Mustang Bio, Inc. | -51.6 Million USD | 448.285% |
| Immunovant, Inc. | -259.33 Million USD | 169.301% |
| Quantum-Si incorporated | -95.96 Million USD | 287.288% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 346.705% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 1027.31% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 287.23% |
| Acasti Pharma Inc. | -12.85 Million USD | 1498.288% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 900.263% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 1225.961% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 198.536% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 4278.107% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 1541.235% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 709.413% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 560.967% |
| PepGen Inc. | -78.62 Million USD | 328.578% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 703.722% |
| United Therapeutics Corporation | 984.8 Million USD | 81.75% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 907.376% |
| Solid Biosciences Inc. | -96.01 Million USD | 287.181% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 3850.877% |
| Immuneering Corporation | -53.47 Million USD | 436.107% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 3632.946% |
| Silo Pharma, Inc. | -3.7 Million USD | 4956.455% |
| Belite Bio, Inc | -31.63 Million USD | 668.165% |
| XOMA Corporation | -40.83 Million USD | 540.161% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 430.584% |
| Bionomics Limited | -15.49 Billion USD | 101.16% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 313.993% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 716.394% |
| uniQure N.V. | -308.47 Million USD | 158.261% |
| Cassava Sciences, Inc. | -97.21 Million USD | 284.867% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 2557.998% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 245.606% |
| Forte Biosciences, Inc. | -31.47 Million USD | 670.981% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 2291.277% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 718.281% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 33692.897% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 785.125% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 1190.215% |
| Altimmune, Inc. | -88.44 Million USD | 303.197% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 218.563% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 716.394% |
| Compugen Ltd. | -18.75 Million USD | 1058.313% |
| Peak Bio, Inc. | -1259.26 USD | 14272132.781% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 490.284% |
| Benitec Biopharma Inc. | -21.75 Million USD | 926.27% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 153.048% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 316.653% |
| Zura Bio Limited | -60.36 Million USD | 397.75% |
| PolyPid Ltd. | -23.86 Million USD | 853.078% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 1242.398% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 316.653% |
| Instil Bio, Inc. | -156.08 Million USD | 215.142% |
| argenx SE | -295.05 Million USD | 160.912% |
| Immunome, Inc. | -106.8 Million USD | 268.27% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 522.935% |
| Verona Pharma plc | -54.36 Million USD | 430.56% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 279.871% |
| Shattuck Labs, Inc. | -87.29 Million USD | 305.872% |
| CervoMed Inc. | -2.17 Million USD | 8374.977% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 244.18% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 1449.67% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 512.632% |
| Moolec Science SA | -51.78 Million USD | 447.028% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 1039452.338% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 233.012% |
| AnaptysBio, Inc. | -163.61 Million USD | 209.842% |
| Design Therapeutics, Inc. | -66.86 Million USD | 368.795% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 320.751% |
| NeurAxis, Inc. | -14.62 Million USD | 1328.727% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 574.426% |
| Lumos Pharma, Inc. | -34.03 Million USD | 628.066% |
| Achilles Therapeutics plc | -69.66 Million USD | 357.98% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 279.871% |
| 180 Life Sciences Corp. | -19.93 Million USD | 1001.535% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -5873.232% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 7086286.978% |
| Nutriband Inc. | -5.48 Million USD | 3376.421% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 278.478% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 469.745% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 333.13% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 629.061% |
| MoonLake Immunotherapeutics | -36 Million USD | 599.127% |
| Palisade Bio, Inc. | -12.3 Million USD | 1561.154% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 526.65% |
| Beam Therapeutics Inc. | -132.52 Million USD | 235.612% |
| Neurogene Inc. | -36.31 Million USD | 594.87% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 209.979% |
| AEON Biopharma, Inc. | -52.55 Million USD | 441.963% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 283.115% |
| Sesen Bio, Inc. | -19.88 Million USD | 1003.852% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 351.064% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 1536.179% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 140.475% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 261.09% |
| Athira Pharma, Inc. | -117.67 Million USD | 252.731% |
| Vaccinex, Inc. | -20.25 Million USD | 987.472% |
| HCW Biologics Inc. | -24.99 Million USD | 819.053% |
| XOMA Corporation | -40.83 Million USD | 540.161% |
| Nektar Therapeutics | -276.05 Million USD | 165.103% |
| Arvinas, Inc. | -367.3 Million USD | 148.931% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 267046.899% |
| Merus N.V. | -154.93 Million USD | 215.995% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 284.466% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 672.637% |
| Rezolute, Inc. | -68.45 Million USD | 362.525% |
| Clene Inc. | -49.5 Million USD | 463.045% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 1265.25% |
| BeyondSpring Inc. | -21.02 Million USD | 954.761% |
| Synlogic, Inc. | -57.28 Million USD | 413.75% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 1610.142% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 1760.096% |
| Peak Bio, Inc. | -1259.26 USD | 14272132.781% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 580.952% |
| Krystal Biotech, Inc. | 10.93 Million USD | -1543.999% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 225.593% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 155.281% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 3990.958% |
| MannKind Corporation | -11.93 Million USD | 1605.462% |
| Ikena Oncology, Inc. | -68.16 Million USD | 363.653% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 955.208% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 293.389% |
| Gossamer Bio, Inc. | -179.81 Million USD | 199.947% |
| CohBar, Inc. | -11.96 Million USD | 1602.426% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 796.921% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 696.093% |
| Legend Biotech Corporation | -518.25 Million USD | 134.678% |
| Mural Oncology plc | -207.44 Million USD | 186.635% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 244.803% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | 1082.639% |
| Disc Medicine, Inc. | -76.42 Million USD | 335.149% |
| Champions Oncology, Inc. | -7.27 Million USD | 2570.066% |
| REGENXBIO Inc. | -263.49 Million USD | 168.207% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 1793.402% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 478.322% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 573.158% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 279.43% |
| Vaxart, Inc. | -82.46 Million USD | 317.937% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -53747.191% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 578.716% |
| Cellectis S.A. | -101.05 Million USD | 277.839% |
| Longeveron Inc. | -21.41 Million USD | 939.313% |
| Repare Therapeutics Inc. | -93.79 Million USD | 291.609% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 133.532% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 352.528% |
| Revolution Medicines, Inc. | -436.36 Million USD | 141.186% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 2835.078% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 683.059% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 359.216% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 377.64% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 1931.842% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 95.035% |
| Denali Therapeutics Inc. | -145.22 Million USD | 223.755% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 149551.993% |
| Veru Inc. | -93.15 Million USD | 292.933% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 764.923% |
| Cingulate Inc. | -23.53 Million USD | 863.639% |
| Passage Bio, Inc. | -102.06 Million USD | 276.091% |
| Context Therapeutics Inc. | -23.96 Million USD | 849.96% |
| Exicure, Inc. | -16.91 Million USD | 1162.564% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 195.133% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 575.908% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 2861.842% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 197.316% |
| Nuvalent, Inc. | -126.21 Million USD | 242.389% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 1809.09% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 306.865% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 688.404% |
| OmniAb, Inc. | -50.61 Million USD | 455.048% |
| Anew Medical, Inc. | 1.34 Million USD | -13251.063% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 1220.112% |
| Lipocine Inc. | -16.35 Million USD | 1199.077% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 370.69% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 382.249% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 525.944% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 474.678% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 1006.268% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 133.19% |
| Ocugen, Inc. | -63.07 Million USD | 384.92% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 287.735% |
| Q32 Bio Inc. | -112.96 Million USD | 259.101% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 1145.382% |
| Alumis Inc. Common Stock | -154.99 Million USD | 215.955% |
| Equillium, Inc. | -13.33 Million USD | 1447.747% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 397.721% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 2349.946% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 1053.37% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 404.191% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 256.925% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | 1077.922% |
| Dominari Holdings Inc. | -22.88 Million USD | 885.43% |
| Edesa Biotech, Inc. | -8.37 Million USD | 2246.084% |
| vTv Therapeutics Inc. | -20.25 Million USD | 987.516% |
| Bio-Techne Corporation | 168.1 Million USD | -6.911% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 151.045% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -39.478% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 247.516% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 573.713% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 259.551% |
| Nkarta, Inc. | -117.5 Million USD | 252.954% |
| BioCardia, Inc. | -11.57 Million USD | 1653.211% |
| Iterum Therapeutics plc | -38.37 Million USD | 568.38% |